SPIT
F/m Emerald Special Situations ETF
F/m Emerald Special Situations ETF seeks to achieve long-term capital appreciation by investing primarily in undervalued securities with the potential for significant price appreciation.
US
EQUITY
Active
MANAGEMENT STYLE
$ 34.8 M
ASSETS UNDER MGMT
105 bp
EXPENSES
Fund Basics
| Inception date | Aug 01, 2014 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| CORCEPT THERAPEUTICS INC | 5.6 % |
| TETRA TECHNOLOGIES INC | 3.9 % |
| GUARDANT HEALTH, INC. | 3.7 % |
| AMAZON.COM INC | 3.6 % |
| TRAVERE THERAPEUTICS, INC. | 3.0 % |
| EL PASO ELECTRIC CO | 3.0 % |
| LIVANOVA PLC | 3.0 % |
| CREDO TECHNOLOGY GROUP HOLDING LTD. | 2.9 % |
| F/M ULTRASHORT TREASURY INFLATION-PROTEC | 2.9 % |
| TAKE-TWO INTERACTIVE SOFTWRE | 2.6 % |
Constituent Breakdown
| Number of holdings | 43 |
| Herfindahl-Hirschman Index | 256 |
| Wgt avg mkt cap (mns) | $180,390 |
| Large cap (>$10bn) | 37.2% |
| Mid cap ($2-10bn) | 42.0% |
| Small cap (<$2bn) | 17.9% |
| Developed mkts. | 97.1% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 92.8 % |
 |
BRITAIN | 3.0 % |
 |
SINGAPORE | 1.3 % |
Historical Performance
Standardized Performance (as of 08/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 22.9% | -- | -- | -- | -- | -- | -- | 20.5% |
| Dividend Yield | 0.0% | -- | -- | -- | -- | -- | -- | 8.8% |
| Total Returns | 22.9% | -- | -- | -- | -- | -- | -- | 29.3% | Ann. Volatility | 26.0% | -- | -- | -- | -- | -- | -- | 26.1% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 5 |
| ADV traded (mns) | $0 |
| Turnover | 0.5% |
| Avg. Bid/Ask (% of price) | 0.43% |
Technical Indicators
| 30d moving avg. (EMA) | $33.31 |
| Relative strength (RSI) | 58 |
| MACD/Signal | 0.40/0.21 |
| Bollinger Bands (Upper/Lower) | $35.22/$30.89 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. SPIT |
Expenses vs. SPIT |
ALTAR Score™ vs. SPIT |
|---|---|---|---|---|
| LFSC | F/m Emerald Life Sciences Innovation ETF | 22.4% | -26 bp | +0.1% |
| FFOX | FundX Future Fund Opportunities ETF | 14.3% | -5 bp | +3.9% |
| DBSC | Deepwater Beachfront Small Cap ETF | 14.1% | -20 bp | +2.6% |
| GRNJ | Fundstrat Granny Shots US Small & Mid Cap ETF | 11.9% | -30 bp | +2.7% |
| FFND | Future Fund Active ETF | 11.7% | -5 bp | +5.3% |
| ARKQ | ARK Autonomous Technology & Robotics ETF | 10.6% | -30 bp | +1.8% |
| ARKX | ARK Space Exploration & Innovation ETF | 10.4% | -30 bp | +0.7% |
Risk and Returns: SPIT vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 9/5/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
-0.1%
ALTAR SCORE™
1st
PERCENTILE
AVOID
ETFRC RATING
There are 1,408 funds in the US Equity category with an average
ALTAR Score™ of 5.2% and a standard deviation
of 2.0%. SPIT's ALTAR Score™ is approximately -2.7 standard
deviations above the category average. This places SPIT in the 1st percentile
among funds in the category.
Sell-Side Consensus
$39.15
PRICE TARGET
+23.2%
UPSIDE